Home
Watchlist
News
Signals
Picks
DJI
+1.00%
SPX
+0.52%
IXIC
+0.52%
FTSE
+0.72%
N225
+1.43%
AXJO
-0.43%
Log In
Get Started
Home
Watchlist
News
Signals
Picks
Stocks
Add to Watchlist
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.
Company
About Us
Careers
Blog
News
Help & Support
Help Center
Contact Us
Pro Support
Legal
Privacy Policy
Terms of Use
Instagram
YouTube
© 2024 Cashu PTY LTD.
Signals
CTXR
Citius Pharmaceuticals
about 1 month ago
CTXR missed EPS expectations by 3457.42%
0.00%
📡️ Health Care
CTXR
Citius Pharmaceuticals
about 2 months ago
Analysts think CTXR stock price could increase by 1000%
15.95%
📡️ Health Care
CTXR
Citius Pharmaceuticals
4 months ago
CTXR missed EPS expectations by 121.01%
0.00%
📡️ Health Care
CTXR
Citius Pharmaceuticals
4 months ago
Analysts think CTXR stock price could increase by 222%
-43.49%
📡️ Health Care
CTXR
Citius Pharmaceuticals
7 months ago
Analysts think CTXR stock price could increase by 124%
9.89%
📡️ Health Care
CTXR
Citius Pharmaceuticals
7 months ago
CTXR missed EPS expectations by 17.65%
0.00%
📡️ Health Care
CTXR
Citius Pharmaceuticals
7 months ago
CTXR has been granted a new patent
-8.06%
📡️ Health Care
CTXR
Citius Pharmaceuticals
7 months ago
CTXR has been granted a new patent
-8.06%
📡️ Health Care
CTXR
Citius Pharmaceuticals
7 months ago
CTXR has been granted a new patent
-8.06%
📡️ Health Care
CTXR
Citius Pharmaceuticals
8 months ago
CTXR is now overvalued and could go down -50%
0.00%
📡️ Health Care
CTXR
Citius Pharmaceuticals Inc
11 months ago
Analysts think CTXR stock price could increase by 351%
-37.16%
📡️ Health Care
CTXR
Citius Pharmaceuticals Inc
about 1 year ago
Analysts think CTXR stock price could increase by 554%
0.40%
📡️ Health Care
Join our newsletter to keep up to date with us!
Sign Up
Stocks
Health Care
ctxr
Add to Watchlist
Citius Pharmaceuticals
CTXR
+0.20 (+15.04%)
1.53
USD
At close at Jun 27, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials